Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-12-23

FDA Approved: LIOTHYRONINE SODIUM — Supplemental Application (Teva Pharmaceuticals USA, Inc.)

View source ↗

Summary

FDA approved a supplemental application for Liothyronine Sodium by Teva Pharmaceuticals USA, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Liothyronine Sodium (Liothyronine Sodium)

Snippet

SUPPL AP for LIOTHYRONINE SODIUM (LIOTHYRONINE SODIUM)